Kolmar Harald
Clemens-Schöpf-Institut für Biochemie und Organische Chemie, Technische Universität Darmstadt, Germany.
FEBS J. 2008 Jun;275(11):2684-90. doi: 10.1111/j.1742-4658.2008.06440.x. Epub 2008 Apr 24.
Cystine-knot miniproteins are members of a large family of small proteins that are defined by a common structural scaffold which is stabilized by three intramolecular disulfide bonds. Cystine-knot miniproteins display a broad spectrum of therapeutically useful natural biological activities and several family members are marketed as therapeutics or are in clinical development. Because of their extraordinary intrinsic chemical and proteolytic stability they provide promising scaffolds for the introduction of therapeutically relevant functionalities. Several successful engineering efforts have been reported to generate miniproteins with novel activities by rational design via functional loop grafting or by directed evolution via screening of scaffold-constrained random libraries. Owing to their small size they are amenable to recombinant as well as to chemical routes of synthesis, which opens up new avenues in optimizing biological activity, specificity and bioavailability by site-specific modification, introduction of non-natural amino acids or chemical conjugation.
胱氨酸结微型蛋白质是一大类小蛋白质家族的成员,这些小蛋白质由一个共同的结构支架定义,该支架通过三个分子内二硫键得以稳定。胱氨酸结微型蛋白质展现出一系列具有治疗用途的天然生物活性,并且该家族的几个成员已作为治疗药物上市或正处于临床开发阶段。由于它们具有非凡的内在化学稳定性和蛋白水解稳定性,因此为引入具有治疗相关性的功能提供了有前景的支架。据报道,通过功能环嫁接的理性设计或通过筛选支架受限随机文库的定向进化,已经开展了多项成功的工程学研究来生成具有新活性的微型蛋白质。由于它们体积小,因此适合重组合成以及化学合成途径,这为通过位点特异性修饰、引入非天然氨基酸或化学偶联来优化生物活性、特异性和生物利用度开辟了新途径。